Copyright Reports & Markets. All rights reserved.

Global Oncolytic Virus Market Professional Survey Report 2018

Request for Sample of this report
Buy now

Table of Contents

    Global Oncolytic Virus Market Professional Survey Report 2017

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Oncolytic Virus Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Analysis by Types

      • 2.1 Overall Market Performance(Volume)
        • 2.1.1 HSV-based Oncolytic Viruses Market Performance (Volume)
        • 2.1.2 Adenoviruses-based Oncolytic Viruses Market Performance (Volume)
        • 2.1.3 Vaccinia Virus-based Oncolytic Viruses Market Performance (Volume)
        • 2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses Market Performance (Volume)
        • 2.1.5 Newcastle Disease Virus-based Oncolytic Viruses Market Performance (Volume)
      • 2.2 Overall Market Performance(Value)
        • 2.1.1 HSV-based Oncolytic Viruses Market Performance (Value)
        • 2.1.2 Adenoviruses-based Oncolytic Viruses Market Performance (Value)
        • 2.1.3 Vaccinia Virus-based Oncolytic Viruses Market Performance (Value)
        • 2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses Market Performance (Value)
        • 2.1.5 Newcastle Disease Virus-based Oncolytic Viruses Market Performance (Value)

      3 Product Application Market

      • 3.1 Overall Market Performance (Volume)
        • 3.1.1 Pharmaceutical Market Performance (Volume)
        • 3.1.2 Health Care Market Performance (Volume)
        • 3.1.3 Commerical Market Performance (Volume)

      4 Manufacturers Profiles/Analysis

      • 4.1 Merck
        • 4.1.1 Merck Profiles
        • 4.1.2 Merck Product Information
        • 4.1.3 Merck Oncolytic Virus Business Performance
        • 4.1.4 Merck Oncolytic Virus Business Development and Market Status
      • 4.2 Otsuka Pharmaceutical Co
        • 4.2.1 Otsuka Pharmaceutical Co Profiles
        • 4.2.2 Otsuka Pharmaceutical Co Product Information
        • 4.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Business Performance
        • 4.2.4 Otsuka Pharmaceutical Co Oncolytic Virus Business Development and Market Status
      • 4.3 Pfizer
        • 4.3.1 Pfizer Profiles
        • 4.3.2 Pfizer Product Information
        • 4.3.3 Pfizer Oncolytic Virus Business Performance
        • 4.3.4 Pfizer Oncolytic Virus Business Development and Market Status
      • 4.4 Roche
        • 4.4.1 Roche Profiles
        • 4.4.2 Roche Product Information
        • 4.4.3 Roche Oncolytic Virus Business Performance
        • 4.4.4 Roche Oncolytic Virus Business Development and Market Status
      • 4.5 Cold Genesys
        • 4.5.1 Cold Genesys Profiles
        • 4.5.2 Cold Genesys Product Information
        • 4.5.3 Cold Genesys Oncolytic Virus Business Performance
        • 4.5.4 Cold Genesys Oncolytic Virus Business Development and Market Status
      • 4.6 Genelux
        • 4.6.1 Genelux Profiles
        • 4.6.2 Genelux Product Information
        • 4.6.3 Genelux Oncolytic Virus Business Performance
        • 4.6.4 Genelux Oncolytic Virus Business Development and Market Status
      • 4.7 Latima
        • 4.7.1 Latima Profiles
        • 4.7.2 Latima Product Information
        • 4.7.3 Latima Oncolytic Virus Business Performance
        • 4.7.4 Latima Oncolytic Virus Business Development and Market Status
      • 4.8 Neotropix
        • 4.8.1 Neotropix Profiles
        • 4.8.2 Neotropix Product Information
        • 4.8.3 Neotropix Oncolytic Virus Business Performance
        • 4.8.4 Neotropix Oncolytic Virus Business Development and Market Status
      • 4.9 Shanghai Sunway Biotech
        • 4.9.1 Shanghai Sunway Biotech Profiles
        • 4.9.2 Shanghai Sunway Biotech Product Information
        • 4.9.3 Shanghai Sunway Biotech Oncolytic Virus Business Performance
        • 4.9.4 Shanghai Sunway Biotech Oncolytic Virus Business Development and Market Status
      • 4.10 SillaJen
        • 4.10.1 SillaJen Profiles
        • 4.10.2 SillaJen Product Information
        • 4.10.3 SillaJen Oncolytic Virus Business Performance
        • 4.10.4 SillaJen Oncolytic Virus Business Development and Market Status
      • 4.11 Takara Bio
      • 4.12 Theravir

      5 Market Performance for Manufacturers

      • 5.1 Global Oncolytic Virus Capacity (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Oncolytic Virus Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Oncolytic Virus Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.4 Global Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
      • 5.5 Global Oncolytic Virus Gross Margin of Manufacturers 2013-2018
      • 5.6 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 China Market Performance for Manufacturers
        • 6.1.1 China Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 China Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 China Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 China Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 USA Market Performance for Manufacturers
        • 6.2.1 USA Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 USA Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 USA Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 USA Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Europe Market Performance for Manufacturers
        • 6.3.1 Europe Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Europe Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Europe Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Europe Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 Japan Market Performance for Manufacturers
        • 6.4.1 Japan Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 Japan Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 Japan Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 Japan Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Korea Market Performance for Manufacturers
        • 6.5.1 Korea Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Korea Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Korea Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Korea Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration
      • 6.6 India Market Performance for Manufacturers
        • 6.6.1 India Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.6.2 India Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.6.3 India Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.6.4 India Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.6.5 Market Concentration
      • 6.7 Southeast Asia Market Performance for Manufacturers
        • 6.7.1 Southeast Asia Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.7.2 Southeast Asia Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.7.3 Southeast Asia Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.7.4 Southeast Asia Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.7.5 Market Concentration
      • 6.8 South America Market Performance for Manufacturers
        • 6.8.1 South America Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.8.2 South America Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.8.3 South America Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.8.4 South America Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.8.5 Market Concentration

      7 Global Oncolytic Virus Market Performance (Sales Point)

      • 7.1 Global Oncolytic Virus Capacity (K Units) and Market Share by Regions 2013-2018
      • 7.2 Global Oncolytic Virus Sales (K Units) and Market Share by Regions 2013-2018
      • 7.3 Global Oncolytic Virus Revenue (M USD) and Market Share by Regions 2013-2018
      • 7.4 Global Oncolytic Virus Price (USD/Unit) by Regions 2013-2018
      • 7.5 Global Oncolytic Virus Gross Margin by Regions 2013-2018

      8 Development Trend for Regions (Sales Point)

      • 8.1 Global Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.2 China Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.3 USA Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.4 Europe Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.5 Japan Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.6 Korea Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.7 India Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.8 Southeast Asia Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.9 Southeast Asia Oncolytic Virus Capacity and Growth, Sales Value and Growth Rate2013-2018

      9 Development Trend for Regions (Sales Point)

      • 9.1 Global Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.2 China Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.3 USA Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.4 Europe Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.5 Japan Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.6 Korea Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.7 India Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.8 Southeast Asia Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.9 South America Oncolytic Virus Sales and Growth, Sales Value and Growth Rate2013-2018

      10 Upstream Source, Technology and Cost

      • 10.1 Upstream Source
      • 10.2 Technology
      • 10.3 Cost

      11 Channel Analysis

      • 11.1 Market Channel
      • 11.2 Distributors

      12 Consumer Analysis

      • 12.1 Pharmaceutical Industry
      • 12.2 Health Care Industry
      • 12.3 Commerical Industry

      13 Market Forecast 2019-2024

      • 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        • 13.1.1 Global Oncolytic Virus Capacity (K Units) and Share by Regions 2019-2024
        • 13.1.2 Global Oncolytic Virus Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
        • 13.1.3 China Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.4 USA Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.5 Europe Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.6 Japan Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.7 Korea Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.8 India Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.9 Southeast Asia Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.10 South America Oncolytic Virus Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        • 13.3.1 Overall Market Performance
        • 13.3.2 HSV-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.3 Adenoviruses-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.4 Vaccinia Virus-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.5 Vesicular Stomatitis Virus-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.4 Sales by Application 2019-2024
        • 13.4.1 Overall Market Performance
        • 13.4.2 Pharmaceutical Sales and and Growth Rate 2019-2024
        • 13.4.3 Health Care Sales and and Growth Rate 2019-2024
        • 13.4.4 Commerical Sales and and Growth Rate 2019-2024
      • 13.5 Price (USD/Unit) and Gross Profit
        • 13.5.1 Global Oncolytic Virus Price (USD/Unit) Trend 2019-2024
        • 13.5.2 Global Oncolytic Virus Gross Profit Trend 2019-2024

      14 Conclusion

      This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
      Merck
      Otsuka Pharmaceutical Co
      Pfizer
      Roche
      Cold Genesys
      Genelux
      Latima
      Neotropix
      Shanghai Sunway Biotech
      SillaJen
      Takara Bio
      Theravir
      ...

      On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
      HSV-based Oncolytic Viruses
      Adenoviruses-based Oncolytic Viruses
      Vaccinia Virus-based Oncolytic Viruses
      Vesicular Stomatitis Virus-based Oncolytic Viruses
      Newcastle Disease Virus-based Oncolytic Viruses

      By Application, the market can be split into
      China
      USA
      Europe
      Japan
      Korea
      India
      Southeast Asia
      South America

      By Regions, this report covers (we can add the regions/countries as you want)

      If you have any special requirements, please let us know and we will offer you the report as you want.

      Buy now